A Prospective, Open-Label Trial of Sirolimus in the Treatment of Focal Segmental Glomerulosclerosis

Clinical Journal of the American Society of Nephrology - United States
doi 10.2215/cjn.00120605
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Response to ‘Treatment of Focal Segmental Glomerulosclerosis’

Kidney International
Nephrology
2010English

Galactose Treatment in Focal and Segmental Glomerulosclerosis

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2014English

The Pathogenesis of Focal Segmental Glomerulosclerosis

Advances in Chronic Kidney Disease
Nephrology
2014English

Genetics of Focal Segmental Glomerulosclerosis

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2007English

Focal Segmental Glomerulosclerosis

American Journal of Medicine
Medicine
1974English

NPHS2variation in Focal and Segmental Glomerulosclerosis

BMC Nephrology
Nephrology
2008English

Pathophysiology and Treatment of Focal Segmental Glomerulosclerosis: The Role of Animal Models

BMC Nephrology
Nephrology
2013English

Infection-Related Focal Segmental Glomerulosclerosis in Children

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Focal Segmental Glomerulosclerosis and Multiple Myeloma.

International Journal of Advanced Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy